CatalystWireBeta

Capital Markets Day

In brief · summary, not quotable

No summary for this filing – the full text is below.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your KMK notes

Capital

Kromek (AIM: KMK), a global detection company delivering best-in-class solutions for the advanced imaging and CBRN detection markets, is hosting a capital markets day (the "CMD") later today for analysts and institutional investors.

The event will provide an opportunity to gain a deeper understanding of the Group's growth strategy, meet members of the wider leadership team and hear from external industry representatives.

As part of the presentations outlining Kromek's plan to deliver sustainable growth, the event will cover:

  • The strong foundations of the Kromek business today
  • Advanced Imaging and CBRN Detection as the key platforms for growth
  • The medium-term target to scale the business to achieve revenues in excess of £60m and a 30% EBITDA margin

Consistent with the Board's focus to further investors' understanding of the strategic value of Kromek's business, the Group confirms that it will be reporting revenue by division with effect from its upcoming results announcement for the financial year to 30 April 2025. At the CMD, management will be providing the following disclosure on revenue by division for the last three reported financial years:

FY 2022FY 2023FY 2024
Advanced Imaging£4.7m£8.7m£9.0m
CBRN Detection£7.3m£8.6m£10.4m
Total Group£12.1m£17.3m£19.4m

No additional new material information is being disclosed and the Group is not providing an update on current trading. In the Group's post year-end trading update of 8 May 2025, Kromek stated that 'as a consequence of the positive financial impact of the partnership with Siemens Healthineers, Kromek expects to report FY 2025 revenue ahead of market expectations, of not less than £26 million, representing year-on-year growth of at least 34%.'

The presentation materials, including a recording, will be available in the Investor Relations section of Kromek's website after the event: https://www.kromek.com/investor-relations/.

The CMD will take place at the offices of Cavendish Capital Markets at One Bartholomew Close, London, EC1A 7BL. Registration is from 2.00pm with the presentations scheduled to run from 2.15pm to 4.20pm followed by Q&A.

Institutional investors and analysts wishing to attend the CMD should register their interest by emailing ir@cavendish.com.

Retail Investor Webinar

The Group is hosting an online Q&A session for retail investors at 5.00pm on Wednesday 25 June 2025 on the Investor Meet Company platform. Questions can be submitted pre-webinar via the Investor Meet Company platform up until 9.00am on 23 June 2025 or at any time during the live webinar. Investors can sign up to Investor Meet Company for free and register to attend the Kromek Q&A session via:

Kromek Group plc

Arnab Basu, CEO Claire Burgess, CFO+44 (0)1740 626 060
Cavendish Capital Markets Limited (Nominated Adviser and Broker)
Geoff Nash/Giles Balleny/Seamus Fricker - Corporate Finance Tim Redfern - ECM Michael Johnson - Sales+44 (0)20 7220 0500
Gracechurch Group (Financial PR)
Harry Chathli/Claire Norbury/Henry Gamble+44 (0)20 4582 3500

Kromek Group plc

Kromek is listed on AIM, a market of the London Stock Exchange, under the trading symbol 'KMK'.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note